Mirion Technologies (Mirion Technologies) ROCE % : -1.61% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Mirion Technologies ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mirion Technologies's annualized ROCE % for the quarter that ended in Mar. 2024 was -1.61%.

Mirion Technologies ROCE % Historical Data

The historical data trend for Mirion Technologies's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mirion Technologies ROCE % Chart

Mirion Technologies Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-0.72

-9.92

-1.75

Mirion Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															-4.52	-2.60	0.29	-0.36	-1.61

Mirion Technologies ROCE % Calculation

Mirion Technologies's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-43.4	/	( ( (2738.7 - 244.3)	+	(2718.5 - 265.7) )	/ 2 )
	=	-43.4	/	( (2494.4	+	2452.8)	/ 2 )
	=	-43.4	/	2473.6
	=	-1.75 %

Mirion Technologies's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-39.2	/	( ( (2718.5 - 265.7)	+	(2648.7 - 234.6) )	/ 2 )
	=	-39.2	/	( ( 2452.8	+	2414.1 )	/ 2 )
	=	-39.2	/	2433.45
	=	-1.61 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Mirion Technologies (NYSE:MIR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mirion Technologies ROCE % Related Terms

Thank you for viewing the detailed overview of Mirion Technologies's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mirion Technologies (Mirion Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Mirion Technologies Inc (NYSE:MIR) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

55I0:Germany

Address

1218 Menlo Drive, Atlanta, GA, USA, 30318

Website

https://www.mirion.com

Mirion Technologies Inc provides products, services, and software that allows customers to safely leverage the power of ionizing radiation for the greater good of humanity through critical applications in the medical, nuclear, defense markets, as well as laboratories, scientific research, analysis and exploration. The Company manages its operations through two segments: Medical and Industrial. The Medical segment provides radiation oncology quality assurance, delivering patient safety solutions for diagnostic imaging and radiation therapy centers. The Industrial segment provides robust, field ready personal radiation detection and identification equipment for defense applications and radiation detection and analysis tools for power plants, labs, and research applications.

Executives

Christopher A. Moore	officer: Chief Accounting Officer (PAO)	C/O MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Loic Eloy	officer: Industrial Group President	1218 MENLO DRIVE, ATLANTA GA 30318
Gsam Holdings Llc	director, 10 percent owner	200 WEST STREET, NEW YORK NY 10282
Michael J Rossi	officer: Medical Group President	230 PARK AVENUE, SUITE 3350, NEW YORK NY 10169
Sheila Rege	director	1218 MENLO DRIVE, ATLANTA GA 30318
Jody Markopoulos	director	3641 WOODBOURNE LANE, CROZET VA 22932
Ccp Ix Lp No. 1	10 percent owner	76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Ccp Ix Lp No. 2	10 percent owner	76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Ccp Ix Co-investment Lp	10 percent owner	76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Ccp Ix Co-investment No. 2 Lp	10 percent owner	76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Charterhouse General Partners (ix) Ltd	10 percent owner	76 BUCKINGHAM PALACE ROAD, 6TH FLOOR, BELGRAVE HOUSE, LONDON X0 SW1W 9TQ
Kipling Matas	officer: Chief Accounting Officer	MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Christopher L Warren	director	MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Brian Schopfer	officer: Chief Financial Officer	MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318
Michael Freed	officer: Chief Operating Officer	MIRION TECHNOLOGIES, INC., 1218 MENLO DRIVE, ATLANTA GA 30318